Development of BioTechnology with Clay Siegall’s


Posted by LLJ43 | Posted in ADC Technology | Posted on 12-05-2017

ClaySiegall is one of the known people in the world he is the CEO and the President of Seattle Genetics organization which was started in the year 1998. His main is to always evolve new ways of developing cancer therapies. The company also advanced due to the better research, scientific innovative and medicine enhancement. He always makes sure he does his daily routine in helping patients suffering from cancer to have a better life. He as well accomplished a lot and also made the company developed rapidly through the introduction of antibody-drug conjugates (ADCs). Seattle Genetics got the ADC product approved by the FDA whereby the drug is supplied to more than 65 countries.


AbbVie, Genentech (Roche) and GlaxoSmithKline are some of the credentials the company accomplished because of the ADC products, whereby they have attained a total of $530 million since they started. More than 20 ADCs have been supplied to various clinical places hence Seattle Genetics helping these clinics to provide better medical care to the people. Clay Siegall is as well is responsible for the organization fund raising projects hence they attained more than $1.2 billion through the private and public sector.


Clay Siegall in the year 1991 to 1997 served at Bristol-Myers Squibb Pharmaceutical Research Institute and also National Cancer Institute. 1988 to 1991 he also served in the National Institutes of Health. Furthermore he is the board member of Ultragenyx Pharmaceutical Washington Roundtable and Alder BioPharmaceuticals. Through his expertise and hard work it made him attain numerous awards which are Pacific Northwest Ernst in the year 2012, Young Entrepreneur of the Year and also in the year 2013 at the University of Maryland as the Graduate of the Year for Math, Natural Sciences and Computer.


He went to the University of Maryland where he got his B.S in Zoology and also attained Ph.D. in Genetics from George Washington University. Clay Siegall also has written more than 70 books for guiding people and also his successful journey of his career.Seattle Genetics main aim is to improve people lives and also treat patients who suffer from cancer through technological antibody therapies.